Anyone who believed the tales told by Investment Bankers duly DESERVED what they get. Suffer the consequences. JP also predicted TG to go down by 50% to RM3.50. Hogwash.
We refer to Pharma’s announcement dated 12 January 2021 in respect of the aforesaid matter.
In this connection, kindly furnish Bursa Securities with the following additional information for public release:
1) Whether PLS possesses the required expertise, knowhow and resources to manufacture the Covid-19 vaccine.
2) The tentative timeframe to enter into the Local Manufacturing Agreement and a Technology and Know-How License Agreement with SINOVAC LS.
3) The risks in relation to the manufacturing of the Covid-19 vaccine that PLS may be exposed to.
4) To elaborate the manner in which PLS intends to market and distribute the Covid-19 vaccine and whether any contract has been secured todate.
5) To specify the relevant authorities’ approvals required for the clinical trial of the Covid-19 vaccine and the manufacturing, distribution and sale of the Covid-19 vaccine in Malaysia together with the status of approval, where applicable.
6) The estimated total capital outlay or costs to be incurred and the source of funding for the manufacturing of Covid- 19 vaccine.
Please furnish Bursa Securities with your reply within one (1) market day from the date hereof.
Pharmaniaga said it had initiated negotiation for the local manufacturing agreement as well as the technology and know-how licence agreement with Sinovac LS, which are expected to be executed within one month
I'm not sure if they're going to manufacture the vaccines but from the announcement, they managed to procure ready vaccines to be used and in bulk (for the fill and finish). Bear in mind that we're in a pandemic and that many high economic activities are under MCO. My guess is that the bulk of vaccines they've procured will also be allocated and prioritized to KKM and private hospitals.
Don't see this as a race between Pharma and Duopharma as even with PFE's and Sinovac's vaccines secured, we're still short to cover the target 80% population. And each person will require 2 doses. Profitability wise, this is a good additional mid-term revenue source for PHARMA and I don't see it going away anytime soon. Even with other vaccines supply, the fill and finish approach is still the most practical to reduce overall vaccines cost to users. I highly doubt PFE or others would allow manufacturing locally and not sure if it's feasible to transport huge bulk of PFE for fill and finish (imagine to ensure huge tanks at -80 degrees - such technological challenge)
I'm not privy to Duopharma's progress in securing vaccine supplies besides this old post. Anyone has updated information? It's kinda odd since KJ was seen as leading the negotiations for both companies but only announced for PHARMA. Did Duopharma's negotiation fell apart?
Good explanation benny Same principle of business happen in uae, whereby government purchases such vaccines and government agencies distribute to the uae people including ex. Hopefully Pharmaniaga will get profits for that.
Norway has expressed increasing concern about the safety of the Pfizer-BioNTech vaccine on elderly people with serious underlying health conditions after raising an estimate of the "number who died after receiving inoculations to 29".
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
chuosyew
11 posts
Posted by chuosyew > 2021-01-13 21:48 | Report Abuse
please read, only found mandarin. sinovac vaccine ia safe. the trial at brasil is use for frontliner.